Patents by Inventor Irfan Qureshi

Irfan Qureshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of riluzole prodrugs to treat Alzheimer's disease
    Patent number: 12201618
    Abstract: Disclosed are methods of treating Alzheimer's Disease by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
    Type: Grant
    Filed: January 18, 2021
    Date of Patent: January 21, 2025
    Assignee: Biohaven Therapeutics Ltd.
    Inventors: Vladimir Coric, Robert Berman, Irfan Qureshi
  • Use of riluzole prodrugs to treat alzheimer's disease
    Patent number: 12161633
    Abstract: Disclosed are methods of treating Alzheimer's Disease by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
    Type: Grant
    Filed: July 20, 2019
    Date of Patent: December 10, 2024
    Assignee: Biohaven Therapeutics Ltd.
    Inventors: Vladimir Coric, Robert Berman, Irfan Qureshi
  • METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH MYELOPEROXIDASE INHIBITOR
    Publication number: 20230130225
    Abstract: Provided is a method for treating amyotrophic lateral sclerosis, including administering to a subject in need of such treatment an effective amount of a myeloperoxidase inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 5, 2021
    Publication date: April 27, 2023
    Inventors: Irfan QURESHI, Marianne FROST, Mary K. DONOHUE
  • USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES
    Publication number: 20220218673
    Abstract: Disclosed are methods of treating a disease in a patient in need thereof, comprising administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of riluzole, or a pharmaceutically acceptable salt thereof, in the form of an oral solid molded fast-dispersing dosage form. Pharmaceutical compositions and kits are also disclosed.
    Type: Application
    Filed: May 26, 2019
    Publication date: July 14, 2022
    Inventors: Vladimir Coric, Robert Berman, Irfan Qureshi
  • USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
    Publication number: 20210290599
    Abstract: Disclosed are methods of treating Alzheimer's Disease by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
    Type: Application
    Filed: July 20, 2019
    Publication date: September 23, 2021
    Inventors: Vladimir Coric, Robert Berman, Irfan Qureshi
  • USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
    Publication number: 20210212999
    Abstract: Disclosed are methods of treating Alzheimer's Disease by administering to a patient in need thereof a riluzole prodrug such as troriluzole. Pharmaceutical compositions and kits including the riluzole prodrugs are also disclosed.
    Type: Application
    Filed: January 18, 2021
    Publication date: July 15, 2021
    Inventors: Vladimir Coric, Robert Berman, Irfan Qureshi